Synaptix Inc. was founded in 2022 with the mission to develop and market advanced and scientifically engineered, botanically based nutraceutical ingredients to address specific therapeutic applications with the ultimate goal of positively impacting people’s health and wellness.
 

Founder Jeremy Cowie began research and development of the Synaptix Formula in 2018 for the purpose finding a solution for cannabis medical users to help alleviate the risk of experiencing negative induced cannabis effects.